0001415889-24-008492.txt : 20240319
0001415889-24-008492.hdr.sgml : 20240319
20240319161008
ACCESSION NUMBER: 0001415889-24-008492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240316
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferra Joseph J Jr
CENTRAL INDEX KEY: 0001733790
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 24763273
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 FEDERAL STREET
STREET 2: SUITE 1900
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7163711125
MAIL ADDRESS:
STREET 1: 101 FEDERAL STREET
STREET 2: SUITE 1900
CITY: BOSTON
STATE: MA
ZIP: 02110
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
form4-03192024_040301.xml
X0508
4
2024-03-16
0001783032
Elevation Oncology, Inc.
ELEV
0001733790
Ferra Joseph J Jr
C/O ELEVATION ONCOLOGY, INC.
101 FEDERAL STREET, SUITE 1900
BOSTON
MA
02110
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Common Stock
2024-03-16
4
M
0
12562
A
90453
D
Common Stock
2024-03-16
4
F
0
4773
4.39
D
85680
D
Restricted Stock Unit
2024-03-16
4
M
0
12562
0
D
Common Stock
12562
62809
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
25% of the RSUs vested on June 16, 2022, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
The RSUs do not expire; they either vest or are canceled prior to the vesting date.
/s/ Robert Yang, Attorney-in-Fact
2024-03-19